LT3528B - Solid preparation based on iphosphamide and method for preparing them - Google Patents

Solid preparation based on iphosphamide and method for preparing them Download PDF

Info

Publication number
LT3528B
LT3528B LTIP921A LTIP921A LT3528B LT 3528 B LT3528 B LT 3528B LT IP921 A LTIP921 A LT IP921A LT IP921 A LTIP921 A LT IP921A LT 3528 B LT3528 B LT 3528B
Authority
LT
Lithuania
Prior art keywords
weight
parts
ifosfamide
tablets
mass
Prior art date
Application number
LTIP921A
Other languages
English (en)
Lithuanian (lt)
Inventor
Dieter Sauerbier
Juergen Engel
Eckhard Milsmann
Klaus Molge
Otto Isaac
Original Assignee
Asta Medica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica Ag filed Critical Asta Medica Ag
Publication of LTIP921A publication Critical patent/LTIP921A/xx
Publication of LT3528B publication Critical patent/LT3528B/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
LTIP921A 1990-08-03 1993-09-03 Solid preparation based on iphosphamide and method for preparing them LT3528B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4024683 1990-08-03
SG181694A SG181694G (en) 1990-08-03 1994-12-30 Solid oral administration forms containing ifosfamide as active agent

Publications (2)

Publication Number Publication Date
LTIP921A LTIP921A (en) 1995-03-27
LT3528B true LT3528B (en) 1995-11-27

Family

ID=25895607

Family Applications (1)

Application Number Title Priority Date Filing Date
LTIP921A LT3528B (en) 1990-08-03 1993-09-03 Solid preparation based on iphosphamide and method for preparing them

Country Status (33)

Country Link
US (1) US5158776A (pt)
EP (1) EP0469440B1 (pt)
JP (2) JP3061898B2 (pt)
KR (1) KR0177170B1 (pt)
CN (1) CN1046851C (pt)
AR (1) AR247484A1 (pt)
AT (1) ATE110261T1 (pt)
AU (2) AU643309B2 (pt)
BG (1) BG60900B1 (pt)
CA (1) CA2048367C (pt)
CZ (1) CZ280475B6 (pt)
DE (2) DE59102620D1 (pt)
DK (1) DK0469440T3 (pt)
EG (1) EG19690A (pt)
ES (1) ES2058999T3 (pt)
FI (1) FI97951C (pt)
HK (1) HK15695A (pt)
HR (1) HRP920575B1 (pt)
HU (1) HU206268B (pt)
IE (1) IE66378B1 (pt)
IL (1) IL99031A (pt)
LT (1) LT3528B (pt)
LV (1) LV10043B (pt)
MC (1) MC2274A1 (pt)
MX (1) MX9100441A (pt)
NO (1) NO178252C (pt)
NZ (1) NZ239222A (pt)
PT (1) PT98532B (pt)
RO (1) RO113611B1 (pt)
SG (1) SG181694G (pt)
SI (1) SI9111342B (pt)
SK (2) SK279740B6 (pt)
ZA (1) ZA916124B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996010996A1 (en) * 1993-07-21 1996-04-18 The University Of Kentucky Research Foundation A multicompartment hard capsule with control release properties
ITFI970184A1 (it) * 1997-07-30 1999-01-30 Menarini Farma Ind Composizioni farmaceutiche contenenti vitamina d e calcio,loro preparazione ed uso terapeutico
DE19733305A1 (de) * 1997-08-01 1999-02-04 Asta Medica Ag Pharmazeutische Zusammensetzung enthaltend Ifosfamid und Carnitin
US6103297A (en) * 1998-01-14 2000-08-15 Matsushita Electronics Corporation Method of manufacturing cathode-ray tube
DE19826517B4 (de) * 1998-06-15 2006-03-23 Baxter Healthcare S.A. Verfahren zur Herstellung von Filmtabletten mit Cyclophosphamid als Wirkstoff und daraus hergestellte Cyclophosphamid-Filmtablette
US20040253307A1 (en) * 2003-02-04 2004-12-16 Brian Hague Sugar-free oral transmucosal solid dosage forms and uses thereof
DE102005008797A1 (de) * 2005-02-25 2006-09-07 Baxter International Inc., Deerfield Trofosfamid-haltige Filmtabletten und Verfahren zu deren Herstellung
ES2785391T3 (es) * 2014-01-06 2020-10-06 Shield Tx Uk Ltd Régimen de dosificación de trimaltol férrico
GB201418710D0 (en) 2014-10-21 2014-12-03 Iron Therapeutics Holdings Ag Dosage regimen

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5646807A (en) * 1979-09-27 1981-04-28 Japan Atom Energy Res Inst Production of composition of complex gradually releasing physiologically active substance
DE3111428A1 (de) * 1981-03-24 1982-10-07 Asta-Werke Ag, Chemische Fabrik, 4800 Bielefeld Oxazaphosphorin-4-thio-alkansulfonsaeuren und deren neutrale salze, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
US4618692A (en) * 1981-09-03 1986-10-21 Asta-Werke Aktiengesellschaft 4-carbamoyloxy-oxazaphosphorins
US5019385A (en) * 1984-11-09 1991-05-28 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Novel lymphopine LK 2 and pharmaceutic compositions containing same
EP0254902B1 (de) * 1986-07-11 1991-08-28 ASTA Pharma Aktiengesellschaft Lösungen von Oxazaphosphorinen mit verbesserter Stabilität und Verfahren zu deren Herstellung
DE3804686A1 (de) * 1988-02-15 1989-08-24 Henkel Kgaa Arzneimittel mit einer kombination von cytostatika bzw. hormontherapeutika und phosphonoderivaten

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
SUCKER ET AL.: "Pharmazeutishe technologie"
W.A. RITSCHE: "Die Tablette", pages: 125

Also Published As

Publication number Publication date
IE66378B1 (en) 1995-12-27
NZ239222A (en) 1993-01-27
AU649184B2 (en) 1994-05-12
SK279740B6 (sk) 1999-03-12
KR920003963A (ko) 1992-03-27
IE912774A1 (en) 1992-02-12
JP3545300B2 (ja) 2004-07-21
BG60900B1 (bg) 1996-06-28
FI913710A0 (fi) 1991-08-02
SG181694G (en) 1995-05-12
EP0469440A1 (de) 1992-02-05
IL99031A (en) 1996-09-04
DK0469440T3 (da) 1994-11-14
NO913019L (no) 1992-02-04
HUT59316A (en) 1992-05-28
AU8158991A (en) 1992-02-06
PT98532B (pt) 1999-01-29
FI97951B (fi) 1996-12-13
SK279739B6 (sk) 1999-03-12
DE59102620D1 (de) 1994-09-29
LV10043B (en) 1995-06-20
US5158776A (en) 1992-10-27
HRP920575B1 (en) 1999-04-30
LTIP921A (en) 1995-03-27
RO113611B1 (ro) 1998-09-30
FI97951C (fi) 1997-03-25
NO178252B (no) 1995-11-13
ZA916124B (en) 1992-04-29
ES2058999T3 (es) 1994-11-01
CS240991A3 (en) 1992-03-18
DE4124481A1 (de) 1992-02-06
FI913710A (fi) 1992-02-04
HU206268B (en) 1992-10-28
CA2048367A1 (en) 1992-02-04
PT98532A (pt) 1992-06-30
CA2048367C (en) 2000-05-23
MX9100441A (es) 1992-04-01
IL99031A0 (en) 1992-07-15
EG19690A (en) 1995-09-30
HU912594D0 (en) 1992-01-28
CN1046851C (zh) 1999-12-01
CN1058715A (zh) 1992-02-19
HRP920575A2 (en) 1995-04-30
ATE110261T1 (de) 1994-09-15
SI9111342A (sl) 1998-04-30
CZ280475B6 (cs) 1996-01-17
KR0177170B1 (ko) 1999-03-20
MC2274A1 (fr) 1993-06-23
JP2000229860A (ja) 2000-08-22
AR247484A1 (es) 1995-01-31
EP0469440B1 (de) 1994-08-24
NO913019D0 (no) 1991-08-02
BG94934A (bg) 1993-12-24
AU4483693A (en) 1993-11-11
HK15695A (en) 1995-02-10
JP3061898B2 (ja) 2000-07-10
NO178252C (no) 1996-02-21
JPH04243828A (ja) 1992-08-31
AU643309B2 (en) 1993-11-11
LV10043A (lv) 1994-05-10
SI9111342B (sl) 1998-10-31

Similar Documents

Publication Publication Date Title
FI93608B (fi) Menetelmä ksantaanikumia sisältävän, kiinteän lääkevalmisteen valmistamiseksi
US5211958A (en) Pharmaceutical composition and process for its preparation
JP2013509403A (ja) 速溶性固体剤形
US20050142195A1 (en) Stable pharmaceutical compositions without a stabilizer
EP0250023A1 (en) Nitrofurantoin dosage form
CN105007897A (zh) 含有无定形托伐普坦的口服施用的混悬剂
AU2018420535A1 (en) Edaravone pharmaceutical composition
KR101136655B1 (ko) 레보타이록신 나트륨을 포함하는 제약 제제
LT3528B (en) Solid preparation based on iphosphamide and method for preparing them
US20020143058A1 (en) Process for preparing non-hygroscopic sodium valproate composition
CZ287984B6 (cs) Tableta se zlepšenou biodostupností účinné látky, kyseliny klodronové, a způsob její výroby
SK54297A3 (en) Cisapride extended release oral compositions
CN115089618B (zh) 一种用于防治骨质疏松的药物组合物及其制备方法
EP0319074B1 (en) Pharmaceutical composition and process for its preparation
RU2039553C1 (ru) Твердая лекарственная форма ифосфамида
CN101590038B (zh) 一种口服缓释降压组合物
US20230365536A1 (en) Crystal form of compound and fumaric acid, pharmaceutical composition and method for treating coronavirus-induced diseases
US11655240B1 (en) Crystal form of compound and fumaric acid, pharmaceutical composition and method for treating coronavirus-induced diseases
CN110179763B (zh) 一种羟苯磺酸钙分散片及其制备方法
CA2125620A1 (en) Ipsapirone medicament formulation
KR960008229B1 (ko) 캡토프릴 서방성 정제 및 그의 제조방법
CN109939239A (zh) 药物组合物及其制备方法
CN108186589A (zh) 一种阿折地平组合物

Legal Events

Date Code Title Description
MM9A Lapsed patents

Effective date: 20100903